Back to Search
JEFFREY FORBES, M.D.
M.D.
Anesthesiology Physician
NPI: 1184644841Individual
Specialties, Licenses & Credentials
Anesthesiology PhysicianPrimary
Anesthesiology
Code: 207L00000X
0101045392(VA)
Research & Publications (20)
Bone fractures among postmenopausal patients with endocrine-responsive early breast cancer treated with 5 years of letrozole or tamoxifen in the BIG 1-98 trial.
PMID 19474112·Ann Oncol·2009
3-trial
Advanced glycation end product interventions reduce diabetes-accelerated atherosclerosis.
PMID 15220206·Diabetes·2004
7-preclinical
Advanced glycation: how are we progressing to combat this web of sugar anomalies in diabetic nephropathy.
PMID 15544521·Curr Pharm Des·2004
6-review
Nanomechanics of full-length nebulin: an elastic strain gauge in the skeletal muscle sarcomere.
PMID 19463013·Langmuir·2009
7-preclinical
The effect of salsalate on insulin action and glucose tolerance in obese non-diabetic patients: results of a randomised double-blind placebo-controlled study.
PMID 19104769·Diabetologia·2009
2-rct
c-Jun NH2-terminal kinase activity in subcutaneous adipose tissue but not nuclear factor-kappaB activity in peripheral blood mononuclear cells is an independent determinant of insulin resistance in healthy individuals.
PMID 19258436·Diabetes·2009
8-other
Gastrointestinal fistulae in chronic granulomatous disease.
PMID 19436280·Am J Gastroenterol·2009
5-case
Serum carboxymethyllysine concentrations are reduced in diabetic men with abdominal aortic aneurysms: Health In Men Study.
PMID 19628355·J Vasc Surg·2009
8-other
Is adjuvant chemotherapy of benefit for postmenopausal women who receive endocrine treatment for highly endocrine-responsive, node-positive breast cancer? International Breast Cancer Study Group Trials VII and 12-93.
PMID 18953651·Breast Cancer Res Treat·2009
4-observational
Interactions between advanced glycation end-products (AGE) and their receptors in the development and progression of diabetic nephropathy - are these receptors valid therapeutic targets.
PMID 19149535·Curr Drug Targets·2009
6-review
RAGE-induced cytosolic ROS promote mitochondrial superoxide generation in diabetes.
PMID 19158353·J Am Soc Nephrol·2009
7-preclinical
Is chemotherapy necessary for premenopausal women with lower-risk node-positive, endocrine responsive breast cancer? 10-year update of International Breast Cancer Study Group Trial 11-93.
PMID 18259856·Breast Cancer Res Treat·2009
4-observational
High-density lipoprotein modulates glucose metabolism in patients with type 2 diabetes mellitus.
PMID 19349317·Circulation·2009
4-observational
Gefitinib treatment in hormone-resistant and hormone receptor-negative advanced breast cancer.
PMID 19553291·Ann Oncol·2009
3-trial
A new perspective on therapeutic inhibition of advanced glycation in diabetic microvascular complications: common downstream endpoints achieved through disparate therapeutic approaches?
PMID 19556753·Am J Nephrol·2009
6-review
Oxidative stress as a major culprit in kidney disease in diabetes.
PMID 18511445·Diabetes·2008
6-review
Cardiac inflammation associated with a Western diet is mediated via activation of RAGE by AGEs.
PMID 18477705·Am J Physiol Endocrinol Metab·2008
7-preclinical
Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes.
PMID 18511846·Diabetes·2008
7-preclinical
Oxidative stress and advanced glycation in diabetic nephropathy.
PMID 18448815·Ann N Y Acad Sci·2008
8-other
Therapeutic interruption of advanced glycation in diabetic nephropathy: do all roads lead to Rome?
PMID 18448801·Ann N Y Acad Sci·2008
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1900 ELECTRIC RD
SALEM, VA 24153 - Phone
- (540) 772-7200
Quick Facts
- NPI
- 1184644841
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile